"Leukotriene Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.
| Descriptor ID |
D020024
|
| MeSH Number(s) |
D06.347.565 D27.505.696.399.450.565
|
| Concept/Terms |
Leukotriene Antagonists- Leukotriene Antagonists
- Receptor Antagonists, Leukotriene
- Antagonists, Leukotriene Receptor
- Leukotriene Receptor Antagonists
- Antagonists, Leukotriene
|
Below are MeSH descriptors whose meaning is more general than "Leukotriene Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Leukotriene Antagonists".
This graph shows the total number of publications written about "Leukotriene Antagonists" by people in this website by year, and whether "Leukotriene Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukotriene Antagonists" by people in Profiles.
-
Mismatching Among Guidelines, Providers, and Parents on Controller Medication Use in Children with Asthma. J Allergy Clin Immunol Pract. 2016 Sep-Oct; 4(5):910-6.
-
Comparative safety and costs of stepping down asthma medications in patients with controlled asthma. J Allergy Clin Immunol. 2016 05; 137(5):1373-1379.e3.
-
Asthma Treatments and Mental Health Visits After a Food and Drug Administration Label Change for Leukotriene Inhibitors. Clin Ther. 2015 Jun 01; 37(6):1280-91.
-
Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc. 2015 Feb; 12(2):161-6.
-
Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids. J Allergy Clin Immunol Pract. 2014 Sep-Oct; 2(5):607-13.
-
A comparison of confounding adjustment methods for assessment of asthma controller medication effectiveness. Am J Epidemiol. 2014 Mar 01; 179(5):648-59.
-
Anti-inflammatory treatment after discharge home from the emergency department in adults with acute asthma. J Emerg Med. 2009 Aug; 37(2 Suppl):S35-41.
-
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol. 2008 Dec; 122(6):1127-1135.e8.
-
Asthma drug use and the development of Churg-Strauss syndrome (CSS). Pharmacoepidemiol Drug Saf. 2007 Jun; 16(6):620-6.
-
Safety of leukotriene receptor antagonists in pregnancy. J Allergy Clin Immunol. 2007 Mar; 119(3):618-25.